|Articles|November 1, 2022
Supplements and Featured Publications
- Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 Update
- Volume 28
- Issue 12
What are the current challenges to wider biosimilar use in the United States?
Plain Language Summary
Advertisement
Plain Language Summary
Click the image to open in a new window.
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule
2
New Dermatologic Therapies Make Waves at Maui Derm 2026
3
Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations
4
Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust
5
